Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...

Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed ...

An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...

"Our findings open avenues for biomarkers of therapy response and acquired drug resistance to help guide clinical decisions in individual patients with metastatic prostate cancer throughout the course ...

Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

Practice-changing perioperative therapy, chemo-free combo for CSPC, reducing cognitive eff ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about navigating treatment option in prostate cancer. Advancements in prostate ...

Association of cardiovascular outcomes with GnRH agonist and antagonist therapy in non-metastatic prostate cancer. Addition of 18F-DCFPyL PSMA PET to MRI to avoid unnecessary biopsy in men on active ...